Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya G Glezerman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Genitourinary Cancer|January 7, 2015
Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating PhysiciansKaren A Autio, Azeez Farooki, Ilya G Glezerman, et al.
Journal of the American College of Surgeons|July 11, 2017
Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide PhosphoribosyltransferaseJian Zheng, Ilya G Glezerman, Eran Sadot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2024
Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulationShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
JAMA Oncology|April 24, 2025
Intravenous Magnesium and Cisplatin-Associated Acute Kidney InjuryShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
BMJ (Clinical Research Ed.)|March 27, 2024
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort studyShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Genitourinary Cancer|January 7, 2015
Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating PhysiciansKaren A Autio, Azeez Farooki, Ilya G Glezerman, et al.
Journal of the American College of Surgeons|July 11, 2017
Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide PhosphoribosyltransferaseJian Zheng, Ilya G Glezerman, Eran Sadot, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2024
Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulationShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
JAMA Oncology|April 24, 2025
Intravenous Magnesium and Cisplatin-Associated Acute Kidney InjuryShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
BMJ (Clinical Research Ed.)|March 27, 2024
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort studyShruti Gupta, Ilya G Glezerman, Jamie S Hirsch, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Pageof 3